explore -WSS

explore

author：Wikipedia 2025-08-11 02:16:01 - browse：8898

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.

For more on what we cover, here’s more on PIPEs; here’s the news from Viking Therapeutics; here’s the latest in MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Medicare drug price negotiation program allowed for now

hotspot

focus

WSS

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

After a drawn out lobbying fight, ARPA

FDA seeks to regulate lab

Address the ethical violations that led to 'Three Identical Strangers'

Address the ethical violations that led to 'Three Identical Strangers'

Ambulance rides for just $100? Advisers want major billing fixes

knowledge

explore

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

The Sacklers, horror, and ‘The Fall of the House of Usher’

23andMe had bad news about my health. I wish a person had delivered it

Sudafed saga points to U.S. issues with evaluating older drugs

Tori Bowie and the unacceptable rates of Black maternal death

FDA advisers vote against ALS treatment from BrainStorm

Dobbs anniversary: the lost opportunity of abortion as health care

Free speech concerns arise in wake of journal editor Eisen's firing

After affirmative action ruling, medical educators look to 'holistic review'

Extreme heat events are a public health emergency

leisure time

Diversify hospital leadership teams to protect BIPOC patient health

FDA advisers vote against ALS treatment from BrainStorm

Health tech startups drop sharply from 2021 highs

Ionis has late

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Medicaid, Medicare dual

hotspot

hotspot

focus

focus